Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-24T17:40:25.431Z Has data issue: false hasContentIssue false

P.146 Exploring the Canadian management of aSAH and delayed cerebral ischemia

Published online by Cambridge University Press:  24 June 2022

ME Eagles
Affiliation:
(Calgary)
MA MacLean
Affiliation:
(Halifax)*
M Kameda-Smith
Affiliation:
(Hamilton)
T Duda
Affiliation:
(Hamilton)
A Almojuela
Affiliation:
(Winnipeg)
R Bokhari
Affiliation:
(Montreal)
LM Elkaim
Affiliation:
(Montreal)
C Iorio-Morin
Affiliation:
(Sherbrooke)
AR Persad
Affiliation:
(Saskatoon)
M Rizzuto
Affiliation:
(Vancouver)
SP Lownie
Affiliation:
(Halifax)
SD Christie
Affiliation:
(Halifax)
JS Teitelbaum
Affiliation:
(Montreal)
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Background: Delayed Cerebral Ischemia (DCI) is a complication of aneurysmal subarachnoid hemorrhage (aSAH) and is associated with significant morbidity and mortality. A paucity of high-quality evidence is available to guide the management of DCI. As such, our objective was to evaluate practice patterns of Canadian physicians regarding the management of aSAH and DCI. Methods: The Canadian Neurosurgery Research Collaborative (CNRC) performed a cross-sectional survey of Canadian neurosurgeons, intensivists, and neurologists who manage aSAH. The survey was distributed to members of the Canadian Neurosurgical and Neurocritical Care Societies, respectively. Responses were analyzed using quantitative and qualitative methods. Results: The response rate was 129/340 (38%). Agreement among respondents included the need for intensive care unit admission, use of clinical and radiographic monitoring, and prophylaxis for prevention of DCI. Indications for starting hyperdynamic therapy varied. There was discrepancy in the proportion of patients felt to require intravenous milrinone, intra-arterial vasodilators, or physical angioplasty for treatment of DCI. Most respondents reported their facility does not utilize a standardized definition for DCI. Conclusions: DCI is an important clinical entity for which no consensus exists in management among Canadian practitioners. The CNRC calls for the development of national standards in the diagnosis and management of DCI.

Type
Poster Presentations
Copyright
© The Author(s), 2022. Published by Cambridge University Press on behalf of Canadian Neurological Sciences Federation